1.
de Weerdt I, Koopmans SM, Kater AP, van Gelder M. Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach. Haematologica 2017; 102(10):1629-1639; https://doi.org/10.3324/haematol.2017.164103.